Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A9 | P48067 | 13/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.37 |
| ▸ | DRD2 | P14416 | 1/20 | 0.36 |
| ▸ | DRD4 | P21917 | 1/20 | 0.36 |
| ▸ | OGA | O60502 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16021612 | 0.93 | SLC6A9 (0.44) | SLC6A9 | |
| SCHEMBL9205301 | 0.82 | EGLN1 (0.40) | SLC6A9ALDH1A1 | |
| SCHEMBL19389460 | 0.81 | SLC6A9 (0.37) | SLC6A9ALDH1A1DRD2DRD4 | |
| SCHEMBL23975536 | 0.81 | SLC6A9 (0.36) | SLC6A9 | |
| SCHEMBL1394889 | 0.80 | SLC6A9 (0.42) | SLC6A9ALDH1A1 | |
| SCHEMBL10060134 | 0.80 | CHIT1 (0.37) | SLC6A9ALDH1A1DRD2DRD4 | |
| SCHEMBL19519825 | 0.80 | SLC6A9 (0.37) | SLC6A9DRD2DRD4 | |
| SCHEMBL9024977 | 0.80 | SIGMAR1 (0.35) | SLC6A9SIGMAR1DRD2DRD4 | |
| SCHEMBL30764646 | 0.78 | NPC1 (0.35) | SLC6A9CHRM1DRD2DRD4 | |
| SCHEMBL12544369 | 0.78 | CYP2C19 (0.43) | ALDH1A1CYP2D6CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3939972-A1 | TRIAZINE BASED RADIOPHARMACEUTICALS AND RADIOIMAGING AGENTS | Molecular Insight Pharmaceuticals, Inc. (US) | 2022-01-19 | — | — | EP | disclosed |